BEVERLY JCG LTD. (9QX) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of BEVERLY JCG LTD. S$0.00, price S$0.00, upside -10.0%, quality 47 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch BEVERLY JCG LTD. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Beverly Wilshire Ltd., an investment holding company, engages in the trading and distribution, and medical businesses in Singapore and Malaysia. The company operates through three segments: Trading and Distribution; Aesthetic Medical and Healthcare; and Investment and Others.
Show more
Beverly Wilshire Ltd., an investment holding company, engages in the trading and distribution, and medical businesses in Singapore and Malaysia. The company operates through three segments: Trading and Distribution; Aesthetic Medical and Healthcare; and Investment and Others. The Trading and Distribution segment engages in the trading and distribution of steel raw materials, consumables, instruments, and semi-finished products for steel mills, iron and steel foundries, and aluminum smelters in the Asia-Pacific region, as well as provision of ancillary services. The Aesthetic Medical segment offers aesthetic medical services, including the provision of aesthetic medical, beauty, and wellness services. The Investment and Others segment provides management services, as well as marketing, distribution, and related services. The company provides plastic surgery, cosmetic and reconstructive surgery, aesthetic dental care, cosmetological and aesthetical related treatments, hair transplant, physiotherapy, spa, and reflexology services; healthy aging therapy, health screening and wellness, and medical research services; and operates medical specialist center with outpatient and day care services and activities. It also offers clinical and other general medical services, and beauty salons. The company was formerly known as Beverly JCG Ltd. and changed its name to Beverly Wilshire Ltd. in September 2025. Beverly Wilshire Ltd. was founded in 1987 and is headquartered in Singapore.
Stock analysis
BEVERLY JCG LTD. (9QX) currently trades at 0.0040 SGD, while our model-based Fair Value estimate is 0.0036 SGD, 10.0% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 11 models at a data quality of 80/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
BEVERLY JCG LTD. reported revenue of 9.4M SGD in FY2025 versus 9.0M SGD in FY2021, a compound +1.2%/yr. Reported net income was 46.0K SGD in FY2025.
Key figures
Market cap 10.7M SGD (≈ $8.4M) · P/S ratio 1.24 · Net margin 0.5% · Return on equity −198% · Return on assets (EBIT) −41.1% · Operating margin −19.9% · Revenue (TTM) 8.7M SGD · Revenue growth (YoY) −35.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 69% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −10%, 9QX screens richer than that median.
Fair Value models
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+59.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.5%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.1%
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−94.0% (2020) → −3.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 243 stocks
Beats the industry median on 1/10 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Below median
Fair Value upside−10.0% · Below median
Profitability
Return on assets−5.8% · Bottom 25%
Net margin (TTM)−2.9% · Bottom 25%
Operating margin (TTM)−19.9% · Bottom 25%
Growth and dividend
Revenue growth−35.5% · Bottom 25%
Balance sheet
Debt / equity0.41× · Above median
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is BEVERLY JCG LTD. (9QX) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of 0.0036 SGD versus a price of 0.0040 SGD, about −10% upside (overvalued).
What is the fair value of 9QX?
Our model-based fair value for BEVERLY JCG LTD. is 0.0036 SGD (as of Sep 27, 2026), built from audited fundamentals. The current price: 0.0040 SGD.
What is the quality score of 9QX?
BEVERLY JCG LTD. has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BEVERLY JCG LTD. (9QX)?
Our model-based price target is the fair value of 0.0036 SGD (as of Sep 27, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the BEVERLY JCG LTD. stock forecast for 2026?
Our models put fair value at 0.0036 SGD, about −10% upside versus a price of 0.0040 SGD (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of BEVERLY JCG LTD. (9QX)?
BEVERLY JCG LTD. reported trailing-twelve-month revenue of about 8.7M SGD (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of BEVERLY JCG LTD. (9QX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BEVERLY JCG LTD. it is 0.0036 SGD per share (as of Sep 27, 2026), against a price of 0.0040 SGD. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is BEVERLY JCG LTD. stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 9QX trades above its calculated fair value: price 0.0040 SGD, fair value 0.0036 SGD, a gap of about −10% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9QX?
No. The price is what the market pays today (0.0040 SGD); the fair value is what the company's own numbers justify (0.0036 SGD). For BEVERLY JCG LTD. the two are 0.0004 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is BEVERLY JCG LTD. worth?
The market values BEVERLY JCG LTD. at about 10.7M SGD (market capitalisation, as of Sep 27, 2026). Per share that is 0.0040 SGD; our models calculate a fair value of 0.0036 SGD per share.
How solid is the balance sheet of BEVERLY JCG LTD. (9QX)?
Balance-sheet figures for BEVERLY JCG LTD. (as of Sep 27, 2026): return on equity −197.9%, debt of 0.41 per unit of equity. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is 9QX from its 52-week high?
BEVERLY JCG LTD. trades at 0.0040 SGD, about 69% below its 52-week high of 0.0130 SGD and at the low of 0.0040 SGD (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0036 SGD is for.
Which stocks are comparable to BEVERLY JCG LTD.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BEVERLY JCG LTD. stock attractive at the current price?
The data as of Sep 27, 2026: price 0.0040 SGD, calculated fair value 0.0036 SGD (−10%), Quality Score 47/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 9QX calculated?
We run BEVERLY JCG LTD. through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 0.0036 SGD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. BEVERLY JCG LTD. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BEVERLY JCG LTD. (9QX)?
The closing price on Oct 2, 2026 was 0.0040 SGD. Our model-based fair value is 0.0036 SGD, about −10% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BEVERLY JCG LTD. right now?
Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual. Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.
Key figures of BEVERLY JCG LTD.
How large is the market capitalisation of BEVERLY JCG LTD. (9QX)?
The market capitalisation of BEVERLY JCG LTD. is 10.7M SGD (≈ $8.4M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BEVERLY JCG LTD. (9QX)?
The price-to-sales ratio of BEVERLY JCG LTD. is 1.24 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of BEVERLY JCG LTD. (9QX)?
The net margin of BEVERLY JCG LTD. is 0.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of BEVERLY JCG LTD. (9QX)?
The return on equity (ROE) of BEVERLY JCG LTD. is −198% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of BEVERLY JCG LTD. (9QX)?
On an EBIT basis the return on assets of BEVERLY JCG LTD. is −41.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of BEVERLY JCG LTD. (9QX)?
The operating margin of BEVERLY JCG LTD. is −19.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at BEVERLY JCG LTD. (9QX)?
Revenue at BEVERLY JCG LTD. is growing −35.5% versus a year earlier (3y avg −3.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does BEVERLY JCG LTD. (9QX) generate?
The free cash flow of BEVERLY JCG LTD. is −1.2M SGD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does BEVERLY JCG LTD. (9QX) carry?
The net debt of BEVERLY JCG LTD. is 798K SGD (fiscal year 2023). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch BEVERLY JCG LTD. in the live analysis
One click puts BEVERLY JCG LTD. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
